True Wealth Design
EIKN icon

True Wealth Design’s Eikon Therapeutics EIKN Stock Holding History

True Wealth Design’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$362 Buy
+45
New +$453 ﹤0.01% 2224

Other funds holding EIKN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Regents of the University of California
Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

True Wealth Design's EIKN Position: Q3 2026 in Review

True Wealth Design opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 45 shares worth $362. The stake represents ﹤0.01% of the portfolio and ranks #2224 among its holdings.

29 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • True Wealth Design held 45 shares of Eikon Therapeutics worth $362 as of Q3 2026.
  • Eikon Therapeutics was a new True Wealth Design position in Q3 2026.
  • Eikon Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2224 holding.
  • 29 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.